Company / Interest Expense per Share
ImmunityBio, Inc. Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.07
FY2025
5-year range
$0.02 / $0.31
FY2021-FY2025
Trend
-58.2%
vs FY2024
Sector context
#28 of 43
Health Care
What the data says
At $0.07, ImmunityBio, Inc.'s interest expense per share ranks #16 of 43 in the Health Care sector. Interest Expense per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2017 to $0.31 in FY2023.
Based on SEC 10-K filings.
0.07 in FY2025 with a 5-year CAGR of -5.0%.
Improved from $0.31 to $0.07 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -23.5%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
#16 of 43 in Health CareTop 35% of 43This company $0.07 Sector average $9.80
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 58.2% year-over-year.
- Ranks #28 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2023.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -58.2% |
| FY2024 | $0.17 | -44.1% |
| FY2023 | $0.31 | +91.4% |
| FY2022 | $0.16 | +930.9% |
| FY2021 | $0.02 | -83.2% |
| FY2020 | $0.09 | +23.1% |
| FY2019 | $0.07 | - |
| FY2018 | - | - |
| FY2017 | $0.00 | -100.0% |
| FY2016 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026